Oncostatin M and its receptor are markers of endoscopic and histological disease activity in Inflammatory Bowel Disease

被引：0
|
作者：
Nguyen, A. [1 ,2 ,3 ]
Sturm, G. [4 ]
Plattner, C. [4 ]
Trajanoski, Z. [4 ]
Atreya, R. [5 ]
Siegmund, B. [2 ,3 ]
Hegazy, A. N. [2 ,3 ,6 ,7 ]
机构：
[1] Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia
[2] Charite Univ Med Berlin, Berlin, Germany
[3] Humboldt Univ, Med Dept Gastroenterol Infectiol & Rheumatol, Berlin, Germany
[4] Med Univ Innsbruck, Bioctr, Inst Bioinformat, Innsbruck, Austria
[5] Friedrich Alexander Univ, Univ Klinikum Erlangen, Med Klin 1, Erlangen, Germany
[6] BIH, Berlin, Germany
[7] German Rheumatism Res Ctr DRFZ, Inflammatory Mech, Berlin, Germany
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P247
引用
收藏
页码：I397 / I398
页数：2
相关论文
共 50 条
  • [1] A role for oncostatin M in inflammatory bowel disease
    Kim, Walter M.
    Kaser, Arthur
    Blumberg, Richard S.
    NATURE MEDICINE, 2017, 23 (05) : 535 - 536
  • [2] A role for oncostatin M in inflammatory bowel disease
    Walter M Kim
    Arthur Kaser
    Richard S Blumberg
    Nature Medicine, 2017, 23 : 535 - 536
  • [3] Endoscopic and histological grading in inflammatory bowel disease
    D'Haens, G.
    IBD 2007 - ACHIEVEMENTS IN RESEARCH AND CLINICAL PRACTICE, 2008, 159 : 71 - 74
  • [4] Endoscopic Disease Activity in Inflammatory Bowel Disease
    Ket S.N.
    Palmer R.
    Travis S.
    Current Gastroenterology Reports, 2015, 17 (12) : 1 - 5
  • [5] Expression of Inflammatory Factors and Its Correlation with Endoscopic Disease Activity in the Patients with Inflammatory Bowel Disease
    Zhu, Lei
    INFLAMMATORY BOWEL DISEASES, 2017, 23 : S65 - S65
  • [6] The role of new inflammatory indices in the prediction of endoscopic and histological activity in inflammatory bowel disease patients
    Cesaro, Nicola
    Valvano, Marco
    Monaco, Sabrina
    Stefanelli, Gianpiero
    Fabiani, Stefano
    Vernia, Filippo
    Necozione, Stefano
    Viscido, Angelo
    Latella, Giovanni
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2025, 37 (01) : 24 - 32
  • [7] CORRELATION BETWEEN CLINICAL, ENDOSCOPIC AND HISTOLOGICAL ACTIVITY IN INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE STUDY
    Neri, B.
    Ruffa, A.
    Romeo, S.
    Zorzi, F.
    Calabrese, E.
    Grasso, E.
    Palmieri, G.
    Biancone, L.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : E109 - E110
  • [8] Serum oncostatin M is a potential biomarker of disease activity and infliximab response in inflammatory bowel disease measured by chemiluminescence immunoassay
    Cao, Ying
    Dai, Yibei
    Zhang, Lingyu
    Wang, Danhua
    Yu, Qiao
    Hu, Wen
    Wang, Xuchu
    Yu, Pan
    Ping, Ying
    Sun, Tao
    Sang, Yiwen
    Liu, Zhenping
    Chen, Yan
    Tao, Zhihua
    CLINICAL BIOCHEMISTRY, 2022, 100 : 35 - 41
  • [9] Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonresponse in Inflammatory Bowel Disease
    Verstockt, Sare
    Verstockt, Bram
    Machiels, Kathleen
    Vancamelbeke, Maaike
    Ferrante, Marc
    Cleynen, Isabelle
    De Hertogh, Gert
    Vermeire, Severine
    INFLAMMATORY BOWEL DISEASES, 2021, 27 (10) : 1564 - 1575
  • [10] Role of Oncostatin M in the prognosis of inflammatory bowel disease: A meta-analysis
    Yang, Yue
    Fu, Kan-Zuo
    Pan, Gu
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2024, 16 (01):
12345